Kymera Therapeutics, Inc. (KYMR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.57B |
| Enterprise Value | 6.29B |
| P/E Ratio | -35.37 |
| PEG Ratio | -6.36 |
| Price/Sales Ratio | 90.07 |
| Price/Book Ratio | 7.48 |
| Enterprise/Revenue | 89.67 |
| Enterprise/EBITDA | -32.16 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.85 |
| Operating Margin | -3.34 |
AD
Management Effectiveness
| Return On Assets | -0.18 |
| Return On Equity | -0.22 |
Income Statement
| Revenue | 39.2M |
| Revenue/Share | 1.07 |
| Gross Profit | 39.2M |
| EBITDA | -303.06M |
| Net Income | -311.4M |
| Diluted EPS | -3.69 |
Balance Sheet
| Total Cash | 690.99M |
| Total Cash/Share | 7.04 |
| Total Debt | 82.22M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 9.83 |
| Book Value Per Share | 15.34 |
Price History
| 52-Week Change | 144.65 |
| 52-Week High | 130.05 |
| 52-Week Low | 45.84 |
| Moving Average 50 Days | 114.39 |
| Moving Average 200 Days | 89.87 |
Statistics
| Average Volume | 858,604 |
| Shares Outstanding | 82.26M |
| % Held by Institutions | 99.35 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
